Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Apr-24 4:02 PM View:  | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 12-Apr-24 | Gift | 150 | -- | -- | (< 1%) 138.57K to 138.42K | |
| 09-Apr-24 4:38 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 09-Apr-24 | Sale | 4,000 | $74.31 | $297,245.00 | (3%) 142.57K to 138.57K | |
| 09-Apr-24 4:38 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 09-Apr-24 | Option Exercise | 28,605 | $6.67 | $190,795.00 | 20% 142.57K to 171.17K | |
| 09-Apr-24 4:38 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 09-Apr-24 | Option Sale | 28,605 | $74.31 | $2,125,670.00 | (17%) 171.17K to 142.57K | |
| 18-Mar-24 7:02 PM View: | Callos Andrew EVP, Chief Commercial Officer | Cytokinetics Inc. (CYTK) | 14-Mar-24 | Grant | 16,941 | -- | -- | 36% 46.95K to 63.89K | |
| 18-Mar-24 6:52 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 14-Mar-24 | Grant | 61,490 | -- | -- | 15% 403.9K to 465.39K | |
| 18-Mar-24 7:07 PM View: | Wong Robert VP, Chief Accounting Officer | Cytokinetics Inc. (CYTK) | 14-Mar-24 | Grant | 4,079 | -- | -- | 16% 25.59K to 29.66K | |
| 18-Mar-24 6:57 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 14-Mar-24 | Grant | 21,333 | -- | -- | 18% 121.23K to 142.57K | |
| 07-Mar-24 4:18 PM View: | Callos Andrew EVP, Chief Commercial Officer | Cytokinetics Inc. (CYTK) | 06-Mar-24 | Payment of Exercise | 5,103 | $66.88 | $341,289.00 | (10%) 52.05K to 46.95K | |
| 07-Mar-24 4:22 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 06-Mar-24 | Payment of Exercise | 16,725 | $66.88 | $1,118,570.00 | (4%) 420.62K to 403.9K | |
| 07-Mar-24 4:26 PM View: | Wong Robert VP, Chief Accounting Officer | Cytokinetics Inc. (CYTK) | 06-Mar-24 | Payment of Exercise | 857 | $66.88 | $57,316.20 | (3%) 26.44K to 25.59K | |
| 07-Mar-24 4:24 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 06-Mar-24 | Payment of Exercise | 8,109 | $66.88 | $542,330.00 | (6%) 129.34K to 121.23K | |
| 05-Mar-24 4:05 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 05-Mar-24 | Option Exercise | 28,604 | $6.67 | $190,789.00 | 20% 142.97K to 171.58K | |
| 05-Mar-24 4:05 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 05-Mar-24 | Planned Option Sale | 28,604 | $67.56 | $1,932,380.00 | (17%) 171.58K to 142.97K | |
| 05-Mar-24 4:05 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 05-Mar-24 | Sale (Planned) | 4,000 | $67.56 | $270,225.00 | (3%) 142.97K to 138.97K | |
| 07-Mar-24 4:22 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 04-Mar-24 | Payment of Exercise | 25,341 | $67.68 | $1,715,080.00 | (6%) 445.96K to 420.62K | |
| 07-Mar-24 4:26 PM View: | Wong Robert VP, Chief Accounting Officer | Cytokinetics Inc. (CYTK) | 04-Mar-24 | Payment of Exercise | 1,783 | $67.68 | $120,673.00 | (6%) 28.23K to 26.44K | |
| 07-Mar-24 4:24 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 04-Mar-24 | Payment of Exercise | 9,630 | $67.68 | $651,758.00 | (7%) 142.97K to 133.34K | |
| 07-Mar-24 4:18 PM View: | Callos Andrew EVP, Chief Commercial Officer | Cytokinetics Inc. (CYTK) | 04-Mar-24 | Payment of Exercise | 2,202 | $67.68 | $149,031.00 | (4%) 54.25K to 52.05K | |
| 14-Feb-24 4:04 PM View: | Henderson John T Director | Cytokinetics Inc. (CYTK) | 14-Feb-24 | Planned Option Sale | 5,000 | $76.48 | $382,400.00 | (10%) 47.72K to 42.72K | |
| 14-Feb-24 4:04 PM View: | Henderson John T Director | Cytokinetics Inc. (CYTK) | 14-Feb-24 | Option Exercise | 5,000 | $4.44 | $22,200.00 | 12% 42.72K to 47.72K | |
| 13-Feb-24 4:01 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 13-Feb-24 | Option Exercise | 12,500 | $6.67 | $83,375.00 | 3% 445.96K to 458.46K | |
| 13-Feb-24 4:01 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 13-Feb-24 | Planned Option Sale | 12,500 | $76.85 | $960,625.00 | (3%) 458.46K to 445.96K | |
| 06-Feb-24 4:43 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 06-Feb-24 | Planned Option Sale | 28,605 | $79.30 | $2,268,310.00 | (16%) 175.58K to 146.97K | |
| 06-Feb-24 4:43 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 06-Feb-24 | Option Exercise | 28,605 | $6.67 | $190,795.00 | 19% 146.97K to 175.58K | |
| 06-Feb-24 4:43 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 06-Feb-24 | Sale (Planned) | 4,000 | $79.30 | $317,190.00 | (3%) 146.97K to 142.97K | |
| 02-Feb-24 4:41 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 31-Jan-24 | Option Exercise | 12,500 | $6.67 | $83,375.00 | 3% 445.96K to 458.46K | |
| 02-Feb-24 4:41 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 31-Jan-24 | Planned Option Sale | 12,500 | $79.57 | $994,625.00 | (3%) 458.46K to 445.96K | |
| 22-Jan-24 5:19 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 19-Jan-24 | Option Exercise | 12,500 | $6.67 | $83,375.00 | 3% 445.96K to 458.46K | |
| 22-Jan-24 5:19 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 19-Jan-24 | Planned Option Sale | 12,500 | $81.42 | $1,017,750.00 | (3%) 458.46K to 445.96K | |
| 12-Jan-24 5:20 PM View: | Henderson John T Director | Cytokinetics Inc. (CYTK) | 12-Jan-24 | Planned Option Sale | 5,000 | $85.14 | $425,700.00 | (10%) 47.72K to 42.72K | |
| 12-Jan-24 5:20 PM View: | Henderson John T Director | Cytokinetics Inc. (CYTK) | 12-Jan-24 | Option Exercise | 5,000 | $4.44 | $22,200.00 | 12% 42.72K to 47.72K | |
| 04-Jan-24 4:36 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 04-Jan-24 | Planned Option Sale | 11,678 | $86.98 | $1,015,780.00 | (7%) 162.65K to 150.97K | |
| 04-Jan-24 4:36 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 04-Jan-24 | Option Exercise | 11,678 | $7.96 | $92,956.90 | 8% 150.97K to 162.65K | |
| 04-Jan-24 4:36 PM View: | Malik Fady Ibraham EVP Research & Development | Cytokinetics Inc. (CYTK) | 04-Jan-24 | Sale (Planned) | 4,000 | $86.98 | $347,930.00 | (3%) 150.97K to 146.97K | |
| 03-Jan-24 4:20 PM View: | Harrington Robert Arthur Director | Cytokinetics Inc. (CYTK) | 02-Jan-24 | Grant | 148 | $84.12 | $12,449.80 | 1% 11.37K to 11.52K | |
| 03-Jan-24 4:21 PM View: | Henderson John T Director | Cytokinetics Inc. (CYTK) | 02-Jan-24 | Grant | 252 | $84.12 | $21,198.20 | < 1% 42.46K to 42.72K | |
| 03-Jan-24 4:29 PM View: | Wysenski Nancy Director | Cytokinetics Inc. (CYTK) | 02-Jan-24 | Grant | 74 | $84.12 | $6,224.88 | < 1% 17.08K to 17.16K | |
| 02-Jan-24 5:55 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 02-Jan-24 | Option Exercise | 12,500 | $6.67 | $83,375.00 | 3% 445.96K to 458.46K | |
| 02-Jan-24 5:55 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 02-Jan-24 | Planned Option Sale | 12,500 | $85.08 | $1,063,500.00 | (3%) 458.46K to 445.96K | |
| 03-Jan-24 4:25 PM View: | Smith Sandford D Director | Cytokinetics Inc. (CYTK) | 02-Jan-24 | Grant | 148 | $84.12 | $12,449.80 | < 1% 18.65K to 18.8K | |
| 03-Jan-24 4:27 PM View: | Wierenga Wendall D Director | Cytokinetics Inc. (CYTK) | 02-Jan-24 | Grant | 74 | $84.12 | $6,224.88 | < 1% 18.65K to 18.73K | |
| 03-Jan-24 4:23 PM View: | Kaye Edward M. Md Director | Cytokinetics Inc. (CYTK) | 02-Jan-24 | Grant | 148 | $84.12 | $12,449.80 | < 1% 19.17K to 19.32K | |
| 27-Dec-23 4:11 PM View: | Wierenga Wendall D Director | Cytokinetics Inc. (CYTK) | 27-Dec-23 | Option Exercise | 10,000 | $4.44 | $44,400.00 | 54% 18.65K to 28.65K | |
| 27-Dec-23 4:11 PM View: | Wierenga Wendall D Director | Cytokinetics Inc. (CYTK) | 27-Dec-23 | Planned Option Sale | 10,000 | $73.60 | $736,000.00 | (35%) 28.65K to 18.65K | |
| 19-Dec-23 4:12 PM View: | Henderson John T Director | Cytokinetics Inc. (CYTK) | 18-Dec-23 | Planned Option Sale | 2,458 | $36.34 | $89,323.70 | (5%) 44.92K to 42.46K | |
| 19-Dec-23 4:13 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 18-Dec-23 | Option Exercise | 12,500 | $6.67 | $83,375.00 | 3% 445.96K to 458.46K | |
| 19-Dec-23 4:13 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 18-Dec-23 | Planned Option Sale | 12,500 | $36.95 | $461,875.00 | (3%) 458.46K to 445.96K | |
| 19-Dec-23 4:12 PM View: | Henderson John T Director | Cytokinetics Inc. (CYTK) | 18-Dec-23 | Option Exercise | 13,020 | $6.72 | $87,494.40 | 41% 31.9K to 44.92K | |
| 01-Dec-23 4:15 PM View: | Blum Robert I President & CEO Director | Cytokinetics Inc. (CYTK) | 30-Nov-23 | Option Exercise | 12,500 | $6.67 | $83,375.00 | 3% 445.58K to 458.08K |
